Currently, the treatment of DN mainly consists of four parts: glycemic control, blood pressure control, inhibition of the renin-angiotensin system, and cardiovascular risk reduction (Umanath and Lewis, 2018). This evidence concerns the gene REN and liver dysplastic nodule.